Vaccine Adjuvants: from 1920 to 2015 and Beyond

Por Di Pasquale, Alberta, Preiss, Scott, Tavares Da Silva, Fernanda, Garçon, Nathalie
Publicado no Vaccines (Basel) (2015)

Safety, Immunogenicity, and Antibody Persistence following an Investigational Streptococcus pneumoniae and Haemophilus influenzae Triple-Protein Vaccine in a Phase 1 Randomized Con...

Por Berglund, Johan, Vink, Peter, Tavares Da Silva, Fernanda, Lestrate, Pascal, Boutriau, Dominique
Publicado em 2014

Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience

Por Angelo, Maria-Genalin, Zima, Julia, Tavares Da Silva, Fernanda, Baril, Laurence, Arellano, Felix
Publicado no Pharmacoepidemiol Drug Saf (2014)

Six‐year multi‐centre, observational, post‐marketing surveillance of the safety of the HPV‐16/18 AS04‐adjuvanted vaccine in women aged 10–25 years in Korea

Por Kim, Chul‐Jung, Song, Rok, Chen, Jing, Tavares Da Silva, Fernanda, Gopala, Kusuma B., Kim, Joon Hyung, Bi, Dan, Park, Jong Sup
Publicado no Pharmacoepidemiol Drug Saf (2017)

Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data

Por Rouse, Caroline E., Eckert, Linda O., Babarinsa, Isaac, Fay, Emily, Gupta, Manish, Harrison, Margo S., Kawai, Alison Tse, Kharbanda, Elyse O., Kucuku, Merita, Meller, Lee, Mallett Moore, Tamala, Subelj, Maja, Kochhar, Sonali, Tavares-Da-Silva, Fernanda
Publicado no Vaccine (2017)